{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T16:47:52Z","timestamp":1773420472644,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1985,1,1]],"date-time":"1985-01-01T00:00:00Z","timestamp":473385600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1985]]},"DOI":"10.1007\/bf00544354","type":"journal-article","created":{"date-parts":[[2004,11,19]],"date-time":"2004-11-19T05:57:08Z","timestamp":1100843828000},"page":"381-386","source":"Crossref","is-referenced-by-count":5,"title":["Treatment of essential hypertension and hypertension associated with renal impairment with pinacidil: A new vasodilator"],"prefix":"10.1007","volume":"28","author":[{"given":"E. G.","family":"Breen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Mulhall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. A. B.","family":"Keogh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/BF01975139","volume":"36","author":"E Arrigoni-Martelli","year":"1980","unstructured":"Arrigoni-Martelli E, Kaergaard Nielsen C, Bang Olsen U, Petersen HJ (1980) N?-cyano-N-4-pyridyl-N?-1,2,2-trimethylpropylguanidine, monohydrate (P1134): a new potent vasodilator. Experientia 36: 445?447","journal-title":"Experientia"},{"issue":"Suppl 1","key":"CR2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2165\/00003495-197600111-00019","volume":"2","author":"RR Bailey","year":"1976","unstructured":"Bailey RR (1976) The kidney and antihypertensive therapy. Drugs 2 [Suppl 1]: 70?77","journal-title":"Drugs"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1136\/bmj.281.6246.982","volume":"281","author":"LT Bannan","year":"1980","unstructured":"Bannan LT, Beevers DG, Wright N (1980) ABC of blood pressure reduction, drug treatment. Br Med J 281: 982?984","journal-title":"Br Med J"},{"key":"CR4","first-page":"523","volume":"8","author":"TG Brien","year":"1967","unstructured":"Brien TG, O'Hagan R, Muldowney FP (1967) Chromium-51-EDTA in the determination of glomerular filtration. Acta Radiol 8: 523?529","journal-title":"Acta Radiol"},{"issue":"Suppl 2","key":"CR5","first-page":"356","volume":"1","author":"JE Carlsen","year":"1983","unstructured":"Carlsen JE, Kardel T, Lund JO, Trap-Jensen J (1983) Immediate haemodynamic effects of pinacidil and hydralazine in essential hypertension, a double-blind randomized crossover study. J Hypertens 1 [Suppl 2]: 356?359","journal-title":"J Hypertens"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1475-097X.1981.tb00905.x","volume":"1","author":"JE Carlsen","year":"1981","unstructured":"Carlsen JE, Kardel T, Hilden T, Tango M, Trap-Jensen J (1981) Immediate central and peripheral haemodynamic effects of a new vasodilating agent pinacidil (P 1134) in hypertensive man. Clin Physiol 1: 375?384","journal-title":"Clin Physiol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/BF00542128","volume":"25","author":"JE Carlsen","year":"1983","unstructured":"Carlsen JE, Kardel T, Jensen H\u00c6, Tango M, Trap-Jensen J (1983) Pinacidil, a new vasodilator: pharmacokinetics and pharmacodynamics of a new retarded release tablet in essential hypertension. Eur J Clin Pharmacol 25: 557?561","journal-title":"Eur J Clin Pharmacol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0002-9343(78)90702-7","volume":"65","author":"K Chatterjee","year":"1978","unstructured":"Chatterjee K, Massie B, Rubin S, Gelberg H, Brundage BH, Ports TA (1978) Long-term out-patient vasodilator therapy of congestive heart failure. Am J Med 65: 134?145","journal-title":"Am J Med"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/00498258209046793","volume":"12","author":"E Eilertsen","year":"1982","unstructured":"Eilertsen E, Magnussen MP, Petersen HJ, Rastrup-Andersen N, Sorensen H, Arrigoni-Martelli E (1982) Metabolism of the new antihypertensive agent pinacidil in rat, dog and man. Xenobiotica 12: 187?196","journal-title":"Xenobiotica"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000166576","volume":"2","author":"MM Friedlaender","year":"1982","unstructured":"Friedlaender MM, Rubinger D, Popovtzer MM (1982) Improved renal function in patients with primary renal disease after control of severe hypertension. Am J Nephrol 2: 12?14","journal-title":"Am J Nephrol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1136\/bmj.2.6047.1293","volume":"2","author":"RM Graham","year":"1976","unstructured":"Graham RM, Thornell IR, Gain JM, Bagnoli C, Oates FG, Stokes GS (1976) Prazosin: the first dose phenomenon. Br Med J 2: 1293?1294","journal-title":"Br Med J"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/0002-9343(72)90050-2","volume":"52","author":"AC Guyton","year":"1972","unstructured":"Guyton AC, Coleman TG, Cowley AW Jr, Scheel KW, Manning RD Jr, Norman RA Jr (1972) Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med 52: 584?594","journal-title":"Am J Med"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1097\/00005344-198109000-00010","volume":"3","author":"T Kardel","year":"1981","unstructured":"Kardel T, Hilden T, Carlsen J, Trap-Jensen J (1981) N?-cyano-N-4-pyridyl-N?-1,2,2-trimethylpropylguanidine, a new vasodilating agent: acute effect on blood pressure and pharmacokinetics in hypertensive patients. J Cardiovasc Pharmacol 3: 1002?1007","journal-title":"J Cardiovasc Pharmacol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJM197608052950606","volume":"295","author":"J Koch-Weser","year":"1976","unstructured":"Koch-Weser J (1976) Hydralazine. N Eng J Med 295: 320?323","journal-title":"N Eng J Med"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"676","DOI":"10.7326\/0003-4819-93-5-676","volume":"93","author":"HC Mitchell","year":"1980","unstructured":"Mitchell HC, Graham RM, Pettinger WA (1980) Renal function during long-term treatment of hypertension with minoxidil. Ann Intern Med 93: 676?681","journal-title":"Ann Intern Med"},{"key":"CR16","first-page":"175","volume":"50","author":"A Mackay","year":"1981","unstructured":"Mackay A, Isles C, Hendersen I, Fife R, Kennedy AC (1981) Minoxidil in the management of intractable hypertension. Q J Med 50: 175?190","journal-title":"Q J Med"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1021\/jm00206a011","volume":"21","author":"HJ Petersen","year":"1978","unstructured":"Petersen HJ, Nielsen KC, Arrigoni-Martelli E (1978) Synthesis and hypotensive activity of N-Alkyl-N?-cyano-N?-pyridylguanidines. J Med Chem 21: 773?781","journal-title":"J Med Chem"},{"key":"CR18","first-page":"569","volume":"43","author":"JE Pohl","year":"1974","unstructured":"Pohl JE, Thurston H, Swales JD (1974) Hypertension with renal impairment: influence of intensive therapy. Q J Med 43: 569?581","journal-title":"Q J Med"},{"key":"CR19","first-page":"249","volume":"14","author":"LE Ramsay","year":"1980","unstructured":"Ramsay LE (1980) Diuretic and beta-blocker in hypertension ? then what? J Roy Coll Phys Lond 14: 249?253","journal-title":"J Roy Coll Phys Lond"},{"key":"CR20","first-page":"280","volume":"52","author":"D Taverner","year":"1983","unstructured":"Taverner D, Bing RF, Heagerty A, Russell GI, Pohl JEF, Swales JD, Thurston H (1983) Improvement of renal function during long-term treatment of severe hypertension with minoxidil. Q J Med 52: 280?287","journal-title":"Q J Med"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1001\/jama.1977.03270480043018","volume":"237","author":"Veterans Administration Co-Operative Study Group on Antihypertensive Agents","year":"1977","unstructured":"Veterans Administration Co-Operative Study Group on Antihypertensive Agents (1977) Propranolol in the treatment of essential hypertension. J Am Med Assoc 237: 2303?2310","journal-title":"J Am Med Assoc"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00544354.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00544354\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00544354","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T22:36:19Z","timestamp":1554417379000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00544354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1985]]}},"alternative-id":["BF00544354"],"URL":"https:\/\/doi.org\/10.1007\/bf00544354","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985]]}}}